Correlation Between Axsome Therapeutics and Immunome

Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Axsome Therapeutics and Immunome, you can compare the effects of market volatilities on Axsome Therapeutics and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and Immunome.

Diversification Opportunities for Axsome Therapeutics and Immunome

-0.15

Correlation Coefficient

Axsome Therapeutics  Immunome

Good diversification

The 3 months correlation between Axsome and Immunome is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and Immunome go up and down completely randomly.

Pair Corralation between Axsome Therapeutics and Immunome

Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 0.53 times more return on investment than Immunome. However, Axsome Therapeutics is 1.88 times less risky than Immunome. It trades about 0.07 of its potential returns per unit of risk. Immunome is currently generating about 0.01 per unit of risk. If you would invest  8,965  in Axsome Therapeutics on September 1, 2024 and sell it today you would earn a total of  857.00  from holding Axsome Therapeutics or generate 9.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Axsome Therapeutics  vs.  Immunome

Axsome Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Axsome Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Axsome Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Immunome

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Immunome has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Immunome is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Axsome Therapeutics and Immunome

The main advantage of trading using opposite Axsome Therapeutics and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.

The idea behind Axsome Therapeutics and Immunome pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.